Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | SCN8A | Q9UQD0 | 5/20 | 0.33 |
| ▸ | SCN10A | Q9Y5Y9 | 5/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL429654 | 0.82 | CYP1A2 (0.40) | L3MBTL1 | |
| SCHEMBL29562631 | 0.82 | CYP1A2 (0.40) | L3MBTL1 | |
| SCHEMBL29545875 | 0.81 | L3MBTL1 (0.40) | L3MBTL1 | |
| SCHEMBL8746461 | 0.81 | L3MBTL1 (0.40) | L3MBTL1 | |
| SCHEMBL4863163 | 0.80 | L3MBTL1 (0.31) | L3MBTL1 | |
| SCHEMBL28456120 | 0.80 | HTR2A (0.40) | APPKCNH2L3MBTL1 | |
| SCHEMBL28472673 | 0.80 | KDM4E (0.39) | L3MBTL1 | |
| SCHEMBL2510510 | 0.79 | S1PR3 (0.42) | L3MBTL1 | |
| SCHEMBL8218479 | 0.79 | S1PR3 (0.42) | L3MBTL1 | |
| SCHEMBL8746439 | 0.79 | S1PR3 (0.42) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2534191-B1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| EP-2534191-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | Rolic AG (CH) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2012-12-13 | — | — | US | disclosed |
| WO-2011098461-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2011-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | LATS1, LATS2, LCP1 | APP 2560/4885MAOB 4449/4885SCN8A 3799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.